On Tuesday, Aquestive Therapeutics Inc (NASDAQ: AQST) opened lower -7.85% from the last session, before settling in for the closing price of $6.62. Price fluctuations for AQST have ranged from $2.12 to $7.55 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 27.90%. Company’s average yearly earnings per share was noted -22.16% at the time writing. With a float of $114.17 million, this company’s outstanding shares have now reached $121.66 million.
Aquestive Therapeutics Inc (AQST) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Aquestive Therapeutics Inc is 6.42%, while institutional ownership is 51.22%. The most recent insider transaction that took place on Nov 17 ’25, was worth 286,209. Before that another transaction happened on Oct 15 ’25, when Company’s Chief Operating Officer sold 67,575 for $7.01, making the entire transaction worth $473,701. This insider now owns 240,771 shares in total.
Aquestive Therapeutics Inc (AQST) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.16 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.13) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -22.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.50% during the next five years compared to 27.90% growth over the previous five years of trading.
Aquestive Therapeutics Inc (NASDAQ: AQST) Trading Performance Indicators
Check out the current performance indicators for Aquestive Therapeutics Inc (AQST). In the past quarter, the stock posted a quick ratio of 5.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Aquestive Therapeutics Inc (AQST)
The latest stats from [Aquestive Therapeutics Inc, AQST] show that its last 5-days average volume of 2.15 million was superior to 2.04 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 64.40%.
During the past 100 days, Aquestive Therapeutics Inc’s (AQST) raw stochastic average was set at 62.43%, which indicates a significant increase from 47.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.37 in the past 14 days, which was higher than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.27, while its 200-day Moving Average is $4.17. Now, the first resistance to watch is $6.47. This is followed by the second major resistance level at $6.84. The third major resistance level sits at $7.03. If the price goes on to break the first support level at $5.91, it is likely to go to the next support level at $5.72. The third support level lies at $5.35 if the price breaches the second support level.
Aquestive Therapeutics Inc (NASDAQ: AQST) Key Stats
There are currently 122,003K shares outstanding in the company with a market cap of 744.22 million. Presently, the company’s annual sales total 57,560 K according to its annual income of -44,140 K. Last quarter, the company’s sales amounted to 12,810 K and its income totaled -15,450 K.
